New Alzheon Peer-Reviewed Scientific Publication Describes Study Design and Baseline Characteristics from APOLLOE4 Phase 3 Trial of Oral ALZ-801/Valiltramiprosate in APOE4/4 Homozygous ...

C-144-01 (ClinicalTrials.gov identifier: NCT02360579) is a phase II study of lifileucel in patients with advanced melanoma who progressed on or after anti–PD-1/PD-L1 therapy. 10 Study design, methods, ...

LIBerate-HoFH study was part of a global registration-enabling Phase 3 program of > 2,900 patients Biologics license application for lerodalcibep submitted to FDA in December 2024 CINCINNATI ...

Together, Krapivin (now a graduate student at the University of Cambridge), Farach-Colton (now at New York University) and Kuszmaul demonstrated in a January 2025 paper that this new hash table can ...